PUTRAJAYA: The Health Ministry has agreed to grant additional indication approval for the product Evusheld 100mg/ml solution for injection (Tixagevimab 100mg/ml and Cilgavimab 100mg/ml) manufactured by Astrazeneca AB of Sweden.
Health director-general Tan Sri Dr Noor Hisham Abdullah said the approval was made at the 383rd Drug Control Authority (DCA) meeting which convened on Thursday (April 6).
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
